About this talk
Americans pay more for prescription drugs than people in most other Western countries. And unfortunately, high drug costs mean low accessibility for many of those in need of life-saving medications. Peter Bach envisions a different approach to pharmaceutical pricing. As Director of Memorial Sloan Kettering Hospital’s Center for Health Policy and Outcomes and the founder of the Drug Pricing Lab, Peter and his team strive to identify more rational approaches to drug pricing and to bring transparency to the process.
Tune in to Peter’s 2017 TEDMED Talk to learn how he is working to balance getting patients the critical treatments they need, while also ensuring drug developers have adequate funding to research, improve, and develop important therapeutics.
About Peter Bach
See more
Peter Bach is a physician, epidemiologist, and a leading expert on the cost and value of drugs in the United States. As the Director of the Center for Health Policy and Outcomes at Memorial Sloan Kettering Cancer Center, he investigates why drugs cost so much and how to make them more affordable for everyone. Peter’s work is all about finding a balance between ensuring new and innovative drugs are developed and making sure they are not so expensive that people can’t afford them. He created the DrugAbacus, a first-of-its-kind interactive tool that helps determine a fair price for a cancer drug based on its actual value to a patient. He has published over 100 articles and editorials in top scientific journals, and he is a member of the National Academy of Medicine. Peter is a trusted voice in the national conversation on drug pricing and is a frequent advisor to policymakers and the media. His research provides the data and evidence needed to push for policy changes that could help lower the cost of medicine while ensuring that future medical breakthroughs are still possible.
